https://www.indianpharmapost.com/astrazeneca-india-receives-esg-rating-of-57-from-crisil-215422026-08-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/pulnovo-medical-enrolls-first-us-patients-in-trial-of-padn-for-heart-disease-linked-pulmonary-hypertension-215432026-08-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/syngene-invests-rs-252-crore-in-renewable-energy-firm-to-support-decarbonisation-strategy-215442026-08-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/japan-approves-bayers-hyrnuo-for-her2-mutant-lung-cancer-215452026-08-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/gossamer-bio-secures-up-to-250-million-financing-to-advance-seralutinib-towards-fda-review-215462026-08-25T00:00:00+05:30always0.9